Accès ouvert
2025
article
OpenAlex
Ahmed M. Arzika, Amza Abdou, Ramatou Maliki, Elodie Lebas et autres
Importance: Mass azithromycin distributions may reduce malaria parasitemia in the short term, but longer-term effectiveness is unclear. Objective: To examine whether biannual mass azithromycin distributions are associated with lower rates of malaria parasitemia in preschool children living in Niger. Design, Setting, and …
Niger, us, gb
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Ahmed M. Arzika, Dallas Mindo‐Panusis, Amza Abdou, Boubacar Kadri et autres
Importance: Because transmission of ocular strains of Chlamydia trachomatis is greatest among preschool-aged children, limiting azithromycin distributions to this age group may conserve resources and result in less antimicrobial resistance, which is a potential advantage in areas with hypoendemic trachoma and limited …
Niger, us, gb
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Ahmed M. Arzika, Ramatou Maliki, Maria M Ali, Mankara K Alio et autres
Importance: Mass azithromycin distributions may decrease childhood mortality, although the causal pathway is unclear. The potential for antibiotics to function as growth promoters may explain some of the mortality benefit. Objective: To investigate whether biannual mass azithromycin distributions are associated with increased …
Niger, us, gb
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Jeremy D. Keenan, Ahmed M. Arzika, Ramatou Maliki, Sanoussi Elh Adamou et autres
BACKGROUND: The Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) trial found that biannual mass distribution of azithromycin to children younger than 5 years in Niger reduced the primary outcome of all-cause mortality by 18%. We aimed …
us, Niger, gb
(code pays fourni par la source)